BR112014017969A8 - Microesferas ou micropartículas bioerodíveis ou bio-degradáveis liberadas por tempo suspensas em uma formulação de droga injetável de formação de depósito - Google Patents
Microesferas ou micropartículas bioerodíveis ou bio-degradáveis liberadas por tempo suspensas em uma formulação de droga injetável de formação de depósitoInfo
- Publication number
- BR112014017969A8 BR112014017969A8 BR112014017969A BR112014017969A BR112014017969A8 BR 112014017969 A8 BR112014017969 A8 BR 112014017969A8 BR 112014017969 A BR112014017969 A BR 112014017969A BR 112014017969 A BR112014017969 A BR 112014017969A BR 112014017969 A8 BR112014017969 A8 BR 112014017969A8
- Authority
- BR
- Brazil
- Prior art keywords
- deposit
- bioerodible
- drug formulation
- microparticles
- injection drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261589681P | 2012-01-23 | 2012-01-23 | |
| PCT/US2013/022466 WO2013112434A1 (en) | 2012-01-23 | 2013-01-22 | Time released biodegradable or bioerodible microspheres or microparticles suspended in a solidifying depot-forming injectable drug formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014017969A2 BR112014017969A2 (enExample) | 2017-06-20 |
| BR112014017969A8 true BR112014017969A8 (pt) | 2017-07-11 |
Family
ID=47630595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014017969A BR112014017969A8 (pt) | 2012-01-23 | 2013-01-22 | Microesferas ou micropartículas bioerodíveis ou bio-degradáveis liberadas por tempo suspensas em uma formulação de droga injetável de formação de depósito |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US20130189369A1 (enExample) |
| EP (1) | EP2806853B1 (enExample) |
| JP (1) | JP6282231B2 (enExample) |
| KR (5) | KR20230104761A (enExample) |
| CN (1) | CN104136006B (enExample) |
| AU (3) | AU2013212583A1 (enExample) |
| BR (1) | BR112014017969A8 (enExample) |
| CA (1) | CA2861348C (enExample) |
| DK (1) | DK2806853T3 (enExample) |
| ES (1) | ES2821526T3 (enExample) |
| HU (1) | HUE050904T2 (enExample) |
| IL (2) | IL233620A0 (enExample) |
| MX (1) | MX364864B (enExample) |
| NZ (1) | NZ627368A (enExample) |
| RU (1) | RU2672596C2 (enExample) |
| WO (1) | WO2013112434A1 (enExample) |
| ZA (1) | ZA201405091B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230104761A (ko) * | 2012-01-23 | 2023-07-10 | 알러간, 인코포레이티드 | 고화 디포-형성 주사가능 약물 제형에 현탁된 서방형생분해성 또는 생체흡수성 미소구체 또는 미립자 |
| US20150335704A1 (en) * | 2014-05-23 | 2015-11-26 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions comprising gels and methods for fabricating thereof |
| US20170112936A1 (en) * | 2014-05-23 | 2017-04-27 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions comprising gels and methods for fabricating thereof |
| CN104306330A (zh) * | 2014-09-24 | 2015-01-28 | 万特制药(海南)有限公司 | 一种盐酸美金刚缓释混悬液及其制备方法 |
| IL295161A (en) | 2015-09-21 | 2022-09-01 | Teva Pharmaceuticals Int Gmbh | Sustained release olanzapine formulation |
| US10441548B2 (en) | 2015-11-12 | 2019-10-15 | Graybug Vision, Inc. | Aggregating microparticles for medical therapy |
| US10682340B2 (en) | 2016-06-30 | 2020-06-16 | Durect Corporation | Depot formulations |
| AU2017290143A1 (en) * | 2016-06-30 | 2019-02-21 | Durect Corporation | Depot formulations |
| CA3057438A1 (en) | 2017-03-20 | 2018-09-27 | Teva Pharmaceuticals International Gmbh | Sustained release olanzapine formulaitons |
| JP2020519585A (ja) | 2017-05-10 | 2020-07-02 | グレイバグ ビジョン インコーポレイテッド | 医学療法のための延長放出マイクロ粒子及びその懸濁液 |
| BR112020000506A2 (pt) * | 2017-07-11 | 2020-07-14 | Sustained Nano Systems Llc | formulações farmacêuticas hipercomprimidas |
| CN107595765A (zh) * | 2017-09-22 | 2018-01-19 | 沈阳兴齐眼药股份有限公司 | 一种眼用缓释药物递送系统及其制备方法 |
| GB2586975B (en) * | 2019-09-09 | 2024-03-06 | Roemex Ltd | Device and method for use with subsea pipelines |
| EP4277661A1 (en) | 2021-01-18 | 2023-11-22 | Anton Frenkel | Pharmaceutical dosage form |
| EP4308106A4 (en) * | 2021-03-15 | 2025-02-26 | Oakwood Laboratories, Llc | MICROSPHERE FORMULATIONS CONTAINING NALTREXONE AND METHODS OF PREPARING AND USING THE SAME |
| CN118284414A (zh) | 2021-07-06 | 2024-07-02 | M·哈斯莱顿 | 血清素再摄取抑制剂戒断综合征的治疗 |
| CN116869914A (zh) * | 2023-05-30 | 2023-10-13 | 庄秉谚 | 无针注射系统的投递物 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5252318A (en) * | 1990-06-15 | 1993-10-12 | Allergan, Inc. | Reversible gelation compositions and methods of use |
| DE69534780T2 (de) * | 1994-04-08 | 2006-10-05 | Qlt Usa Inc., Fort Collins | Flüssige Zusammensetzungen zur Arzneistoffabgabe |
| WO1998027963A2 (en) * | 1996-12-20 | 1998-07-02 | Alza Corporation | Gel composition and methods |
| US6589549B2 (en) * | 2000-04-27 | 2003-07-08 | Macromed, Incorporated | Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles |
| GB0122318D0 (en) * | 2001-09-14 | 2001-11-07 | Novartis Ag | Organic compounds |
| US20070196415A1 (en) * | 2002-11-14 | 2007-08-23 | Guohua Chen | Depot compositions with multiple drug release rate controls and uses thereof |
| CN1314452C (zh) * | 2002-04-22 | 2007-05-09 | 沈阳药科大学 | 具有适宜相转变温度的眼用原位凝胶制剂 |
| KR20050085367A (ko) * | 2002-12-04 | 2005-08-29 | 산텐 세이야꾸 가부시키가이샤 | 결막하 데포에 의한 약물 송달 시스템 |
| US20090148527A1 (en) * | 2007-12-07 | 2009-06-11 | Robinson Michael R | Intraocular formulation |
| US20060182781A1 (en) * | 2004-04-30 | 2006-08-17 | Allergan, Inc. | Methods for treating ocular conditions with cyclic lipid contraining microparticles |
| US7893040B2 (en) * | 2005-07-22 | 2011-02-22 | Oculis Ehf | Cyclodextrin nanotechnology for ophthalmic drug delivery |
| US20070202186A1 (en) * | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
| RU2485941C2 (ru) * | 2007-06-25 | 2013-06-27 | Оцука Фармасьютикал Ко., Лтд. | Микросферы, имеющие структуру ядро/оболочка |
| IN2012DN03361A (enExample) * | 2009-10-01 | 2015-10-23 | Evonik Degussa Corp | |
| CN101816627B (zh) * | 2010-04-16 | 2012-03-07 | 浙江大学 | 一种协同治疗型多物质缓释滴眼剂及制备方法 |
| CN102100663B (zh) * | 2011-01-14 | 2013-04-17 | 华南理工大学 | 一种pH敏感型原位凝胶纳米缓释眼药水的制备方法 |
| KR20230104761A (ko) * | 2012-01-23 | 2023-07-10 | 알러간, 인코포레이티드 | 고화 디포-형성 주사가능 약물 제형에 현탁된 서방형생분해성 또는 생체흡수성 미소구체 또는 미립자 |
-
2013
- 2013-01-22 KR KR1020237021933A patent/KR20230104761A/ko not_active Ceased
- 2013-01-22 KR KR1020207033455A patent/KR20200133286A/ko not_active Ceased
- 2013-01-22 WO PCT/US2013/022466 patent/WO2013112434A1/en not_active Ceased
- 2013-01-22 CA CA2861348A patent/CA2861348C/en active Active
- 2013-01-22 KR KR1020147023407A patent/KR20140114892A/ko not_active Ceased
- 2013-01-22 KR KR1020227010024A patent/KR20220044379A/ko not_active Ceased
- 2013-01-22 ES ES13702182T patent/ES2821526T3/es active Active
- 2013-01-22 KR KR1020207016713A patent/KR102183727B1/ko not_active Expired - Fee Related
- 2013-01-22 CN CN201380010884.2A patent/CN104136006B/zh active Active
- 2013-01-22 MX MX2014008857A patent/MX364864B/es active IP Right Grant
- 2013-01-22 EP EP13702182.0A patent/EP2806853B1/en active Active
- 2013-01-22 BR BR112014017969A patent/BR112014017969A8/pt not_active Application Discontinuation
- 2013-01-22 RU RU2014134420A patent/RU2672596C2/ru active
- 2013-01-22 DK DK13702182.0T patent/DK2806853T3/da active
- 2013-01-22 US US13/746,592 patent/US20130189369A1/en not_active Abandoned
- 2013-01-22 AU AU2013212583A patent/AU2013212583A1/en not_active Abandoned
- 2013-01-22 NZ NZ627368A patent/NZ627368A/en not_active IP Right Cessation
- 2013-01-22 HU HUE13702182A patent/HUE050904T2/hu unknown
- 2013-01-22 JP JP2014553507A patent/JP6282231B2/ja not_active Expired - Fee Related
-
2014
- 2014-07-11 ZA ZA2014/05091A patent/ZA201405091B/en unknown
- 2014-07-13 IL IL233620A patent/IL233620A0/en active IP Right Grant
-
2017
- 2017-11-09 AU AU2017258895A patent/AU2017258895B2/en not_active Ceased
-
2019
- 2019-03-26 IL IL265620A patent/IL265620B/en unknown
- 2019-07-10 AU AU2019204957A patent/AU2019204957A1/en not_active Abandoned
- 2019-12-19 US US16/720,892 patent/US20200297650A1/en not_active Abandoned
-
2022
- 2022-12-27 US US18/146,921 patent/US20230390212A1/en not_active Abandoned
-
2023
- 2023-08-21 US US18/453,123 patent/US20240226022A1/en not_active Abandoned
-
2024
- 2024-04-01 US US18/623,822 patent/US20240423922A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014017969A8 (pt) | Microesferas ou micropartículas bioerodíveis ou bio-degradáveis liberadas por tempo suspensas em uma formulação de droga injetável de formação de depósito | |
| EP2895217A4 (en) | DISPOSAL DEVICES AND METHOD FOR SKIN AUGMENTATION | |
| BR112014031874A2 (pt) | método para preparar células-tronco em concentração elevada | |
| PH12016500691A1 (en) | Smoking article with liquid release component | |
| MX377802B (es) | Metodos y composiciones para trastornos del sueño y otros trastornos. | |
| EP2833849A4 (en) | INTRAOCULAR RELEASE DEVICES AND METHOD THEREFOR | |
| SI2780022T1 (sl) | Farmacevtski preparati humanih rpe celic in njihova uporaba | |
| ECSP10010684A (es) | Agonistas mezclados, basados en gip para el tratamiento de trastornos metabólicos y obesidad. | |
| BRPI0909499A2 (pt) | combinações e métodos para administração subcutâneas de imunoglobina e hialuronidase. | |
| GB201111485D0 (en) | Drug composition and its use in therapy | |
| BR112013012481A2 (pt) | composições e artigos contendo um líquido ativo em uma matriz polimérica e métodos de preparar e usar os mesmos | |
| EP2925340B8 (en) | Pharmaceutical compositions comprising selective agonists of melanocortin 1 receptor and their use in therapeutic methods | |
| MX361778B (es) | Composiciones farmaceuticas y metodos de tratamiento. | |
| PH12016500706A1 (en) | Smoking article with liquid delivery material | |
| BR112013015303A2 (pt) | material de construção acústico empregando quitosana | |
| ES2445846R1 (es) | Una composición de combinación farmacéutica y su uso para preparar un medicamento destinado al tatamiento de la diabetes de tipo l y los trastornos metabólicos | |
| EP2777713A4 (en) | POLYETHYLENE GLYCOL AMINO ACID OLIGOPEPTIDE IRINOTECAN MEDICAMENT CONJUGATE AND MEDICAMENT COMPOSITION THEREOF | |
| MX2016007534A (es) | Composicion de gel de acido hialuronico que tiene durabilidad. | |
| EP2804634A4 (en) | CHROMATOGRAPHIC MEDIA FOR THE STORAGE AND DISPOSAL OF THERAPEUTIC BIOLOGICAL SUBSTANCES AND SMALL MOLECULES | |
| EP2810639A4 (en) | REDISPERIBLE POWDER DISPERSED COSMETICS | |
| EA201390979A1 (ru) | Композиции бензимидазолов с модифицированным высвобождением | |
| EP2560614A4 (en) | PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THEIR ADMINISTRATION | |
| MX341642B (es) | Composicion de liberacion sostenida que contiene peptidos como ingredientes activos. | |
| BR112013005304A2 (pt) | cosméticos de uso prolongado fixados e biofuncionais | |
| EP2682096A4 (en) | COSMETIC BASE MATERIAL AND COSMETICS ITEMS WITH THIS COSMETIC BASE MATERIAL |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 13A ANUIDADE. |